Effect of Armodafinil on Simulated Driving, Electroencephalogram and Cognitive Performance in Sleep Deprived Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 29 May 2017
At a glance
- Drugs Armodafinil (Primary)
- Indications Eating disorders; Fatigue; Hypersomnia
- Focus Pharmacokinetics; Therapeutic Use
- 23 May 2017 Planned End Date changed from 1 Jul 2017 to 31 Dec 2017.
- 23 May 2017 Planned primary completion date changed from 1 Jul 2017 to 31 Dec 2017.
- 23 May 2017 Status changed from not yet recruiting to recruiting.